Raltegravir plus boosted darunavir shown to be safe and effective for first-line ART
HIV attachment inhibitor BMS-663068 shows good safety and efficacy in phase 2b study
Maternal deaths due to HIV not declining despite PMTCT successes in South Africa
HIV incidence at record high in young gay black men in southern USA
People with HIV more likely to die after diagnosis of many common cancers in US
Monkey studies confirm viability of injectable PrEP drug
Sofosbuvir & ribavirin cures 75% of genotype 1 HIV/HCV co-infected patients
AbbVie '3D' combination cures 99% of genotype 1b hepatitis C
Simeprevir cures almost 80% of first-time co-infected hepatitis C patients
